Both in Pharmaceuticals
Axsome Therapeutics vs Ligand Pharmaceuticals
Over the past year AXSM returned +2.8% and LGND returned +63.9%; their daily moves had a correlation of 0.25.
AXSM +2.8% LGND +63.9%Growth of $1, one year, split-adjusted
| Metric | AXSM | LGND |
|---|---|---|
| Price | $139.61 | $313.52 |
| Market cap | $7.31B | $6.27B |
| Today | +2.65% | +2.12% |
| 1 month | −21.2% | +2.2% |
| 6 months | −37.4% | +35.0% |
| Year to date | −23.6% | +65.8% |
| 1 year | +3.4% | +63.9% |
| Revenue growth (YoY) | +51.9% | −31.8% |
| Gross margin | 93.1% | 83.7% |
| Net margin | −5.0% | −36.2% |
| P/E (TTM) | — | 121.9× |
| Price / sales | 8.5× | 24.7× |
| Net cash | $116.6M | -$653.3M |
| Dividend yield | — | — |
| Volatility (60d) | 38.1% | 29.7% |
| Short % of float | 7.6% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).